Leo Polz is partner and co-chair of HOFFMANN EITLE’S biotechnology group.
Dr Polz studied chemistry at the Ludwig Maximilian University of Munich, graduating in 1985, and completed his doctoral thesis in biochemistry in 1989. He conducted research at Chiba University and Kyoto University in Japan in pharmaceutical biology until 1990, where he was engaged in investigation on pharmaceutically active compounds from plant cell cultures, elucidation of the structure and biosynthetic routes of secondary metabolites from plants.
Dr Polz joined HOFFMANN EITLE in 1990, qualifying as a German and European patent attorney in 1994.
Dr Polz has a particular focus on patent litigation, opposition and appeal proceedings before the European and German Patent Offices, the German infringement courts and the German Federal Patents Court. Further, Dr Polz is active in patent prosecution, legal opinions and due diligence work. He has particular expertise in the fields of biochemistry and biotechnology, pharmacology and organic chemistry. Dr Polz has experience in litigation involving therapeutically valuable proteins and biologics, such as blood factors, vaccines, hormones, antibodies (eg, adalimumab and trastuzumab), cell cultures, polymerase chain reaction, CRISPR and screening methods.
Dr Polz is bilingual in German and English and is learning Chinese. He frequently travels to the United States, Japan and China, and has a strong client base in Asia.
- Patent Attorney Bar Association
Register for more free content
- Read more IAM blogs and articles
- Receive the editor's weekly review by email